SCHEMBL24607392

SCHEMBL24607392

CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NC[C@H]1CC[C@H](CO)CC1

nearest known ligand 0.69

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ IRAK4 Q9NWZ3 20/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29751167 1.00 IRAK4 (0.69) IRAK4
SCHEMBL24607174 0.94 IRAK4 (0.69) IRAK4
SCHEMBL24607175 0.94 IRAK4 (0.71) IRAK4
SCHEMBL29751651 0.92 IRAK4 (0.68) IRAK4
SCHEMBL24607389 0.92 IRAK4 (0.68) IRAK4
SCHEMBL29709746 0.91 IRAK4 (0.84) IRAK4
SCHEMBL24508743 0.91 IRAK4 (0.84) IRAK4
SCHEMBL29751255 0.87 IRAK4 (0.65) IRAK4
SCHEMBL24607319 0.87 IRAK4 (0.65) IRAK4
SCHEMBL21949093 0.84 IRAK4 (0.89) IRAK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022147465-A1 IRAK DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2022-07-07 — — WO disclosed
Send feedback